Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Maggioni, A P; Franzosi, M G; Farina, M L; Santoro, E; Celani, M G; Ricci, S; Tognoni, G

Maggioni, A P; Franzosi, M G; Farina, M L; Santoro, E; Celani, M G; Ricci, S; Tognoni, G.

Affiliation

Maggioni AP; Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

BMJ ; 302(6790): 1428-31, 1991 Jun 15.

Article in En | MEDLINE | ID: mdl-2070108

Subject(s)

Cerebrovascular Disorders/etiology; Myocardial Infarction/complications; Streptokinase/therapeutic use; Thrombolytic Therapy; Aged; Blood Pressure; Cerebrovascular Disorders/mortality; Cerebrovascular Disorders/prevention & control; Female; Humans; Incidence; Italy/epidemiology; Male; Middle Aged; Myocardial Infarction/drug therapy; Myocardial Infarction/mortality; Myocardial Infarction/physiopathology; Prognosis; Risk Factors; Streptokinase/adverse effects; Thrombolytic Therapy/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Streptokinase / Thrombolytic Therapy / Cerebrovascular Disorders / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 1991 Type: Article

Fulltext

XML

PubMed Links

Search on Google